Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults with Chronic ITP
- Details
- Category: Amgen
Amgen Inc. (Nasdaq: AMGN) announced the final results from a 5-year open-label extension study investigating the long-term efficacy and safety of Nplate(R) (romiplostim) in adult chronic immune (idiopathic) thrombocytopenic purpura (ITP).
Commitment of Novartis in advancing treatments for patients with cancer and rare diseases
- Details
- Category: Novartis
With more than 170 presentations focused on its marketed and pipeline compounds at key oncology medical congresses in December, Novartis continues to demonstrate progress of its innovative research and development efforts, collaboration with the scientific community and commitment to patients with cancer and rare diseases[1],[2].
Genzyme Completes Sale of Genetic Testing Business to LabCorp
- Details
- Category: Genzyme
Genzyme Corporation (Nasdaq: GENZ) has completed the sale of Genzyme Genetics to Laboratory Corporation of America Holdings (NYSE: LH) for $925 million in cash. Under the final terms of the agreement, LabCorp purchased substantially all of the assets of the Genzyme Genetics business, including testing services, technology,
Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE: BMY) and Alvin Ailey American Dance Theater announced the launch of the 2011 REYATAZ® (atazanavir sulfate) "Fight HIV Your Way" contest. The contest aims to help raise awareness about HIV/AIDS among the general public and inspire people impacted by the disease to continue their fight.
GlaxoSmithKline to increase its shareholding in Theravance
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) (the "Company") announced that GSK will increase its shareholding in Theravance through the purchase of Theravance common stock in a private placement.
GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (GSK) and JSC Binnopharm (Binnopharm) announced an alliance to enable the local secondary manufacture of a number of GSK vaccines in Russia. The agreement was signed in Moscow during the session of the Russian-British Intergovernmental Steering Committee (ISC) for Trade and Investment.
Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets
- Details
- Category: Merck Group
Merck KGaA announced that the U.S. Food and Drug Administration (FDA) has extended its review period for Cladribine Tablets as a therapy for relapsing forms of multiple sclerosis (MS) by three months to February 28, 2011.
More Pharma News ...
- Abbott Named One of the Top 10 Companies in Calvert Diversity Survey
- Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic test
- Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye
- Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
- APPRAISE-2 Study with Investigational Compound Apixaban Discontinued
- Novartis unveils long-term strategy to grow in a dynamically changing healthcare environment
- Genzyme Announces Agreement to Sell Diagnostics Business